All the information you need about JB PHARMA to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2023-02-06 | Public | 2022-09-30 | Complete |
| Name | JB PHARMA |
| Siren | 879879864 |
| Closing | 2022-09-30 |
| Registry code | 6001 |
| Registration number | 639 |
| Management number | 2019D00449 |
| Activity code | 6430Z |
| Closing date n-1 | 2021-09-30 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2023-02-06 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 60510 LA NEUVILLE-EN-HEZ |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
AP Buildings | 339 900.00 | 339 900.00 | 339 900.00 | |
BJ TOTAL (I) | 339 900.00 | 339 900.00 | 339 900.00 | |
BZ Other receivables | 127 684.00 | 127 684.00 | 127 684.00 | |
CF Cash and cash equivalents | 57 008.00 | 57 008.00 | 57 008.00 | |
CJ TOTAL (II) | 184 692.00 | 184 692.00 | 184 692.00 | |
CO Grand total (0 to V) | 524 592.00 | 524 592.00 | 524 592.00 | |
CS Evaluated investments - equity method | 5.00 | |||
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 340 000.00 | 340 000.00 | 340 000.00 | |
DD Legal reserve (1) | 8 488.00 | 421.00 | 8 488.00 | |
DG Other reserves | 161 266.00 | 8 002.00 | 161 266.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | 13 589.00 | 161 330.00 | 13 589.00 | |
DL TOTAL (I) | 523 342.00 | 509 754.00 | 523 342.00 | |
DX Trade payables and related accounts | 1 250.00 | 1 200.00 | 1 250.00 | |
DY Tax and social security liabilities | 3 324.00 | |||
EC TOTAL (IV) | 1 250.00 | 4 524.00 | 1 250.00 | |
EE Grand total (I to V) | 524 592.00 | 514 278.00 | 524 592.00 | |
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FW Other purchases and external expenses | 1 791.00 | |||
FX Taxes, duties, and similar payments | ||||
GE Other Expenses | ||||
GF Total Operating Expenses (II) | 1 791.00 | |||
GG - OPERATING RESULT (I - II) | -1 791.00 | |||
GP Total financial income (V) | 17 778.00 | |||
GV - FINANCIAL INCOME (V - VI) | 17 778.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | 15 987.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HK Income tax | 2 398.00 | 3 324.00 | 2 398.00 | |
HL TOTAL REVENUE (I + III + V + VII) | 17 778.00 | 166 698.00 | 17 778.00 | |
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) | 4 189.00 | 5 368.00 | 4 189.00 | |
HN PROFIT OR LOSS (Total revenue - Total expenses) | 13 589.00 | 161 330.00 | 13 589.00 | |
| 8 - Receivables and payables | Gross amount | Amount within 1 year | Amount 1 to 5 years | Amount more than 5 years |
8B Suppliers and Related Accounts | 1 250.00 | 1 250.00 | 1 250.00 | |
VR Miscellaneous debtors (including receivables related to repo transactions) | 127 684.00 | 127 684.00 | 127 684.00 | |
VT TOTAL – STATEMENT OF RECEIVABLES | 127 684.00 | 127 684.00 | 127 684.00 | |
VY TOTAL – STATEMENT OF LIABILITIES | 1 250.00 | 1 250.00 | 1 250.00 | |
